Advertisement
There is an inverse correlation between sleep duration and risk markers of type 2 diabetes in childhood

Sleep Duration Inversely Linked to Risk Markers of T2DM in Kids

0
Strong inverse correlations between sleep duration, adiposity, diabetes risk markers in children
There is considerable variation in nonparticipation in diabetes self-management classes

Variation in Participation in Diabetes Self-Management Class

0
Nonparticipation varies by race/ethnicity, education, health care coverage, county, time since diagnosis
For rodents with diabetes

Hyperglycemia May Cause Caries but Not Periodontal Disease

0
Findings in rodent models of type 1 and type 2 diabetes
Subcutaneous exendin appears to be safe and effective in treating post-bariatric hypoglycemia

Subcutaneous Exendin Treats Post-Bariatric Hypoglycemia

0
Injections well tolerated with no adverse effects reported
Glucose metabolism and weight are associated with marrow fat behavior

Marrow Fat May Affect Bone Mass After Roux-en-Y Gastric Bypass

0
Negative independent association seen for marrow fat and bone mineral density changes
There is a non-linear association between caloric load and reward

Taste, Calories Affect Metabolic Response to Sugared Beverages

0
Metabolic responses up for lower calorie beverages, and when sweetness is proportional to caloric load
Sustained and meaningful improvements in hemoglobin A1c are seen with participation in a diabetes self-management education game

Team-Based Online Game May Improve Glycemic Control in T2D

0
Participation in diabetes self-management education game linked to sustained HbA1c reduction
Risk factors for dementia include black race

Midlife Vascular Risk Factors Tied to Increased Risk of Dementia

0
Vascular risk factors linked to dementia include midlife smoking, diabetes, hypertension
Diabetes in infancy has different characteristics depending on mutation subtype

Characteristics of Diabetes in Infancy Explored

0
Overall frequency of diabetic ketoacidosis 66.2 percent; odds increase with age at diagnosis
For patients newly diagnosed with type 1 diabetes

Peptide Immunotx Well Tolerated in New-Onset Type 1 Diabetes

0
No decline in C-peptide with peptide immunotherapy; no change in insulin use over 12 months